- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05691283
Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project
August 19, 2025 updated by: Peter Tsai, University of Texas Southwestern Medical Center
Right Lateralized Posterior Cerebellar tDCS in Children With Autism Spectrum Disorder
The purpose of this research study is to investigate the effects of transcranial direct current stimulation (tDCS) on some of the challenges faced by children with Autism Spectrum Disorder (ASD).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will be randomized, double-blind, within subject crossover design.
It will involve a group of 30-40 children and young adults with Autism Spectrum Disorder (ASD).
We may recruit up to 60 subjects.
Diagnosis of ASD will be confirmed with the Autism Diagnostic Interview-Revised (ADI-R) or Autism Diagnostic Observation Schedule-2 (ADOS-2) by a research-reliable clinician.
Each participant will undergo a sham condition and a transcranial direct current stimulation (tDCS) condition, the order of sham and tDCS conditions will be randomly assigned to each participant during baseline testing.
Sham refers to participants only receiving 1 milliamp of tDCS stimulation for 1 minute, and tDCS stimulation refers to 20 minutes of tDCS stimulation.
The study involves an initial screening visit followed by two sessions with three months between each session period.
Each session includes the following: pre-testing and imaging, tDCS 3-week session, post-testing and imaging.
Participants will complete an initial screening to confirm clinical diagnosis of ASD, determine baseline cognitive functioning, and complete a practice Magnetic Resonance Imaging (MRI) and Magnetoencephalography (MEG) session.
At pre-testing, they will complete a psychometric battery, as well as undergo safety screening, and an MRI and/or MEG.
Each 3-week tDCS sessions will be randomized, and each participant will undergo three weeks of sham stimulation and three weeks of 20-minute tDCS stimulation.
Neither the researchers nor the participants will know which group they are assigned during each three-week session.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Haley Walker
- Phone Number: 214-797-6454
- Email: Autism@utsouthwestern.edu
Study Locations
-
-
Texas
-
Dalls, Texas, United States, 75390-8568
- Recruiting
- UT Southwestern Medical Center
-
Contact:
- Haley Walker
- Email: Haley.walker@utsouthwestern.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ages 5 to 21, male and female, with known autism spectrum disorder as diagnosed by a clinician
Exclusion Criteria:
- Pregnancy
- Brain implants
- Pacemakers
- Any biomedical or metal implants in any part of body
- Hearing or visual impairment
- History of brain injury
- Known brain or skull abnormality other than those that may be associated with ASD
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: transcranial direct current stimulation (tDCS), then sham stimulation
Participants receives three weeks of 20-minute tDCS stimulation.
After a washout period of 3 months, they then receive three weeks of sham stimulation
|
Three weeks of sham stimulation
Three weeks of 20-minute tDCS stimulation
|
|
Experimental: Sham stimulation, then transcranial direct current stimulation (tDCS)
Participants receives three weeks of sham stimulation.
After a washout period of 3 months, they then receive three weeks of 20-minute tDCS stimulation
|
Three weeks of sham stimulation
Three weeks of 20-minute tDCS stimulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social behavior as measured by Reading the Mind in the Eyes (RME) Child Version
Time Frame: Baseline
|
Reading the Mind in the Eyes (RME) Child Version will be used to measure complex mental state recognition.
This test consists of 28 photographs of the eye region of the human face, each surrounded by four words.
Participants pick the word that best describes what the person in the photo is thinking or feeling.
Scores range from 0-28, higher score indicates very accurate at decoding a person's facial expressions around their eyes.
|
Baseline
|
|
Social behavior as measured by Reading the Mind in the Eyes (RME) Child Version
Time Frame: Post Treatment (approx at 3 month)
|
Reading the Mind in the Eyes (RME) Child Version will be used to measure complex mental state recognition.
This test consists of 28 photographs of the eye region of the human face, each surrounded by four words.
Participants pick the word that best describes what the person in the photo is thinking or feeling.
Scores range from 0-28, higher score indicates very accurate at decoding a person's facial expressions around their eyes.
|
Post Treatment (approx at 3 month)
|
|
Social behavior as measured by Cyberball/Social Ball Throwing Task
Time Frame: Baseline
|
Cyberball/Social Ball Throwing Task will be used to measure social interaction.
In this task, the participant engaged in a virtual ball throwing game with two other players.
There are three conditions the participants will be randomly assigned to.
In two conditions participants are thrown the ball an equal number of times, in the other condition the participant is only thrown the ball a few times.
After the participant completes the task, they are given a rating scale to rate how well they trust and prefer the other two players on a scale from 1-7 (totally mistrust to totally trust).
The ratings indicated how well the subject was able to determine if they were left out of the group"
|
Baseline
|
|
Social behavior as measured by Cyberball/Social Ball Throwing Task
Time Frame: Post Treatment (approx at 3 month)
|
Cyberball/Social Ball Throwing Task will be used to measure social interaction.
In this task, the participant engaged in a virtual ball throwing game with two other players.
There are three conditions the participants will be randomly assigned to.
In two conditions participants are thrown the ball an equal number of times, in the other condition the participant is only thrown the ball a few times.
After the participant completes the task, they are given a rating scale to rate how well they trust and prefer the other two players on a scale from 1-7 (totally mistrust to totally trust).
The ratings indicated how well the subject was able to determine if they were left out of the group"
|
Post Treatment (approx at 3 month)
|
|
Sensorimotor behavior as measured by Grip Strength
Time Frame: Baseline
|
Participants grip a specially designed fiber optic device (Aither Engineering, Inc.).
This device detects nanometer changes in grip force which are calibrated in Newtons.
Participants are instructed to rest their arm in a relaxed position.
Subjects use their thumb and index finger to press against grip device.
Prior to testing, each subject will complete the maximum voluntary contraction for each hand during trials of 3 seconds each with 15 seconds in between each trial.
The subject is then instructed to press as hard as they can when the screen says "go" using only the thumb and pointer finger.
|
Baseline
|
|
Sensorimotor behavior as measured by Grip Strength
Time Frame: Post Treatment (approx at 3 month)
|
Participants grip a specially designed fiber optic device (Aither Engineering, Inc.).
This device detects nanometer changes in grip force which are calibrated in Newtons.
Participants are instructed to rest their arm in a relaxed position.
Subjects use their thumb and index finger to press against grip device.
Prior to testing, each subject will complete the maximum voluntary contraction for each hand during trials of 3 seconds each with 15 seconds in between each trial.
The subject is then instructed to press as hard as they can when the screen says "go" using only the thumb and pointer finger.
|
Post Treatment (approx at 3 month)
|
|
Sensorimotor behavior as measured by Reach Task
Time Frame: Baseline
|
Participants will be positioned at a table with reaching arm resting on the table in a neutral position.
The task includes picking up small objects placed on the table and placing the objects one by one into a target container in two trials: preferred and non-preferred hands.
The task is rated on a 6-point rating scale, where 5 represents weakest performance, and 0 represents best performance.
Each item is given a raw score and a standard score, which translate to a component score and percentile rank.
|
Baseline
|
|
Sensorimotor behavior as measured by Reach Task
Time Frame: Post Treatment (approx at 3 month)
|
Participants will be positioned at a table with reaching arm resting on the table in a neutral position.
The task includes picking up small objects placed on the table and placing the objects one by one into a target container in two trials: preferred and non-preferred hands.
The task is rated on a 6-point rating scale, where 5 represents weakest performance, and 0 represents best performance.
Each item is given a raw score and a standard score, which translate to a component score and percentile rank.
|
Post Treatment (approx at 3 month)
|
|
Sensorimotor behavior as measured by Sensory Profile-2
Time Frame: Baseline
|
A parent self-report form designed to assess sensory processing patterns in children and adolescents.
The report includes three subscales: sensory system, behavior, and sensory pattern.Each item is scored on a Likert scale from 1 to 5 (1=Much Less Than Others, 2=Less Than Others, 3=Just Like the Majority of Others, 4=More Than Others, 5=Much More Than Others).
Raw scores are totaled and converted to percentile ranks based on participant age.
|
Baseline
|
|
Sensorimotor behavior as measured by Sensory Profile-2
Time Frame: Post Treatment (approx at 3 month)
|
A parent self-report form designed to assess sensory processing patterns in children and adolescents.
The report includes three subscales: sensory system, behavior, and sensory pattern.Each item is scored on a Likert scale from 1 to 5 (1=Much Less Than Others, 2=Less Than Others, 3=Just Like the Majority of Others, 4=More Than Others, 5=Much More Than Others).
Raw scores are totaled and converted to percentile ranks based on participant age.
|
Post Treatment (approx at 3 month)
|
|
Neurophysiological impacts as measured by Magnetoencephalography (MEG)
Time Frame: Baseline
|
MEG data will be processed using AFNI (https://afni.nimh.nih.gov/).
Using all channels of the MEG data, strength and latency of responses are measured by transforming each subject's raw MEG activity into brain space.
A spatial filter is applied which separates the source activity from different brain regions to observe overlap at the sensor level.
This analysis will assess functional connectivity between the region of interest (ROI) voxel, the right Crus I of the cerebellum, compared to all other voxels in the brain.
Seed-based voxel correlation analysis enables researchers to see the statistical correlation between the ROI activity and activity in other cortical areas.
This correlation reveals patterns of connectivity between the ROI and other cortical regions.
The second level analysis will utilize a one-way ANOVAs will compare baseline measures (Cyberball, Precision Grip) and demographics (e.g.
age) within groups.
The within subjects' effect of tDCS on task scores will be evaluated
|
Baseline
|
|
Neurophysiological impacts as measured by Magnetoencephalography (MEG)
Time Frame: Post Treatment (approx at 3 month)
|
MEG data will be processed using AFNI (https://afni.nimh.nih.gov/).
Using all channels of the MEG data, strength and latency of responses are measured by transforming each subject's raw MEG activity into brain space.
A spatial filter is applied which separates the source activity from different brain regions to observe overlap at the sensor level.
This analysis will assess functional connectivity between the region of interest (ROI) voxel, the right Crus I of the cerebellum, compared to all other voxels in the brain.
Seed-based voxel correlation analysis enables researchers to see the statistical correlation between the ROI activity and activity in other cortical areas.
This correlation reveals patterns of connectivity between the ROI and other cortical regions.
The second level analysis will utilize a one-way ANOVAs will compare baseline measures (Cyberball, Precision Grip) and demographics (e.g.
age) within groups.
The within subjects' effect of tDCS on task scores will be evaluated
|
Post Treatment (approx at 3 month)
|
|
Neurophysiological impacts as measured by functional magnetic resonance imaging (fMRI)
Time Frame: Baseline
|
fMRI data will be processed using AFNI (https://afni.nimh.nih.gov/).
A regression analyses is used (3dDeconvolve and 3dREML) for each subject.
Data collected from MRI acquisition will be analyzed at two levels.
The first level of analysis will use seed-based voxel correlational analysis, a statistical technique for observing differences in brain activity.
This analysis will assess functional connectivity between the region of interest (ROI) voxel, the right Crus I of the cerebellum, compared to all other voxels in the brain.
Seed-based voxel correlation analysis enables researchers to see the statistical correlation between the ROI activity and activity in other cortical areas.
This correlation reveals patterns of connectivity between the ROI and other cortical regions.
The second level analysis will utilize a one-way ANOVAs will compare baseline measures (Cyberball, Precision Grip) and demographics (e.g.
age) within groups.
|
Baseline
|
|
Neurophysiological impacts as measured by functional magnetic resonance imaging (fMRI)
Time Frame: Post Treatment (approx at 3 month)
|
fMRI data will be processed using AFNI (https://afni.nimh.nih.gov/).
A regression analyses is used (3dDeconvolve and 3dREML) for each subject.
Data collected from MRI acquisition will be analyzed at two levels.
The first level of analysis will use seed-based voxel correlational analysis, a statistical technique for observing differences in brain activity.
This analysis will assess functional connectivity between the region of interest (ROI) voxel, the right Crus I of the cerebellum, compared to all other voxels in the brain.
Seed-based voxel correlation analysis enables researchers to see the statistical correlation between the ROI activity and activity in other cortical areas.
This correlation reveals patterns of connectivity between the ROI and other cortical regions.
The second level analysis will utilize a one-way ANOVAs will compare baseline measures (Cyberball, Precision Grip) and demographics (e.g.
age) within groups.
|
Post Treatment (approx at 3 month)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive functioning as measured by Flanker Inhibitory Control and Attention
Time Frame: Baseline
|
The NIH Toolbox Flanker Inhibitory Control and Attention Test measures both a participant's attention and inhibitory control.
Accuracy and reaction scores range in value between 0 and 5.
If accuracy scores for the participant reach more than 80%, the reaction time score and accuracy score are combined.
Combined scores range in value from 0-10.
This score shows how accurate and how quickly the subject responded, the high the score the more accurate and quickly each subject responded.
|
Baseline
|
|
Executive functioning as measured by Flanker Inhibitory Control and Attention
Time Frame: Post Treatment (approx at 3 month)
|
The NIH Toolbox Flanker Inhibitory Control and Attention Test measures both a participant's attention and inhibitory control.
Accuracy and reaction scores range in value between 0 and 5.
If accuracy scores for the participant reach more than 80%, the reaction time score and accuracy score are combined.
Combined scores range in value from 0-10.
This score shows how accurate and how quickly the subject responded, the high the score the more accurate and quickly each subject responded.
|
Post Treatment (approx at 3 month)
|
|
Executive functioning as measured by Dimensional Card Change Sort
Time Frame: Baseline
|
The Dimensional Change Card Sort (DCCS) is a measure of cognitive flexibility, also known as task switching or set shifting.
Scoring is based on a combination of accuracy and reaction time.
Accuracy and reaction scores range in value between 0 and 5.
If accuracy scores for the participant reach more than 80%, the reaction time score and accuracy score are combined.
Combined scores range in value from 0-10.
This score shows how accurate and how quickly the subject responded, the high the score the more accurate and quickly each subject responded.
|
Baseline
|
|
Executive functioning as measured by Dimensional Card Change Sort
Time Frame: Post Treatment (approx at 3 month)
|
The Dimensional Change Card Sort (DCCS) is a measure of cognitive flexibility, also known as task switching or set shifting.
Scoring is based on a combination of accuracy and reaction time.
Accuracy and reaction scores range in value between 0 and 5.
If accuracy scores for the participant reach more than 80%, the reaction time score and accuracy score are combined.
Combined scores range in value from 0-10.
This score shows how accurate and how quickly the subject responded, the high the score the more accurate and quickly each subject responded.
|
Post Treatment (approx at 3 month)
|
|
Working memory as measured by Stanford Binet-V Working Memory Subtest
Time Frame: Baseline
|
Stanford Binet-V Working Memory Subtest assesses how well the subject recalls facts and objects.
This area assesses how well the subject recalls facts and objects.
At lower levels, the non-verbal test involves asking the subject to find an object hidden under a cup, or block tapping in which the subject must repeat a sequence of tapping on blocks initiated by the examiner.
The verbal test requires the subject to recall the last words of several sentences in a series.
Raw scores are the total number of items correct and are converted into standard scores (0-119) for each subtest based on participant age.
Standard scores of 100-110 are considered average for the subjects age range
|
Baseline
|
|
Working memory as measured by Stanford Binet-V Working Memory Subtest
Time Frame: Post Treatment (approx at 3 month)
|
Stanford Binet-V Working Memory Subtest assesses how well the subject recalls facts and objects.
This area assesses how well the subject recalls facts and objects.
At lower levels, the non-verbal test involves asking the subject to find an object hidden under a cup, or block tapping in which the subject must repeat a sequence of tapping on blocks initiated by the examiner.
The verbal test requires the subject to recall the last words of several sentences in a series.
Raw scores are the total number of items correct and are converted into standard scores (0-119) for each subtest based on participant age.
Standard scores of 100-110 are considered average for the subjects age range
|
Post Treatment (approx at 3 month)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Peter Tsai, MD, PhD, UT Southwestern Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 20, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
December 21, 2022
First Submitted That Met QC Criteria
January 17, 2023
First Posted (Actual)
January 20, 2023
Study Record Updates
Last Update Posted (Estimated)
August 26, 2025
Last Update Submitted That Met QC Criteria
August 19, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU-2022-0689
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on Sham
-
Universidad de AlmeriaSecretaría General de Universidades, Investigación y Tecnología, Junta de...Enrolling by invitationSubstance-Related DisordersSpain
-
Corporacion Parc TauliCompletedFatigue | Inflammatory Bowel DiseaseSpain
-
Instituto Mexicano del Seguro SocialInstituto Nacional de Salud Publica, Mexico; Universidad Nacional Autonoma... and other collaboratorsRecruitingEffect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy (EA&DPN)Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathy | Acupuncture | Diabetic Polyneuropathy | Electroacupuncture | Nerve ConductionMexico
-
University of LeipzigReCor Medical, Inc.RecruitingHeart Failure With Preserved Ejection Fraction | Hypertension, RenalGermany
-
Institut National de la Santé Et de la Recherche...Centre Hospitalier Régional Universitaire MontpellierCompletedChronic Obstructive Pulmonary Disease
-
Vita CareTegos S.A.CompletedOsteoarthritis | Osteoarthritis Hand | Osteoarthritis Finger | Osteoarthritis Both HandsBrazil
-
Oulu University HospitalLoisto Terveys, Oulu; Fysios Kastelli, Oulu; Faskia-Markus, OuluEnrolling by invitationLow Back Pain | Low Back Pain, RecurrentFinland
-
Shanghai Yueyang Integrated Medicine HospitalNot yet recruitingChronic Lichenified Atopic Dermatitis
-
Otolith LabsCompleted